226 related articles for article (PubMed ID: 26938273)
1. Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization.
Take K; Mochida T; Maki T; Satomi Y; Hirayama M; Nakakariya M; Amano N; Adachi R; Sato K; Kitazaki T; Takekawa S
PLoS One; 2016; 11(3):e0150976. PubMed ID: 26938273
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high-fat diet.
Mochida T; Take K; Maki T; Nakakariya M; Adachi R; Sato K; Kitazaki T; Takekawa S
FEBS Open Bio; 2020 Mar; 10(3):316-326. PubMed ID: 31837122
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Human Intestinal MGAT Inhibitors Using High-Throughput Mass Spectrometry.
Adachi R; Ishii T; Matsumoto S; Satou T; Sakamoto J; Kawamoto T
SLAS Discov; 2017 Apr; 22(4):360-365. PubMed ID: 28328319
[TBL] [Abstract][Full Text] [Related]
4. MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice.
Tsuchida T; Fukuda S; Aoyama H; Taniuchi N; Ishihara T; Ohashi N; Sato H; Wakimoto K; Shiotani M; Oku A
Lipids Health Dis; 2012 Jun; 11():75. PubMed ID: 22698140
[TBL] [Abstract][Full Text] [Related]
5. Anti-Obesity and Anti-Diabetic Effect of Neoagarooligosaccharides on High-Fat Diet-Induced Obesity in Mice.
Hong SJ; Lee JH; Kim EJ; Yang HJ; Park JS; Hong SK
Mar Drugs; 2017 Mar; 15(4):. PubMed ID: 28333098
[TBL] [Abstract][Full Text] [Related]
6. A predominant role of acyl-CoA:monoacylglycerol acyltransferase-2 in dietary fat absorption implicated by tissue distribution, subcellular localization, and up-regulation by high fat diet.
Cao J; Hawkins E; Brozinick J; Liu X; Zhang H; Burn P; Shi Y
J Biol Chem; 2004 Apr; 279(18):18878-86. PubMed ID: 14966132
[TBL] [Abstract][Full Text] [Related]
7. Cell-based assay of MGAT2-driven diacylglycerol synthesis for profiling inhibitors: use of a stable isotope-labeled substrate and high-resolution LC/MS.
Onorato JM; Chu CH; Ma Z; Kopcho LM; Chao HJ; Lawrence RM; Cheng D
J Lipid Res; 2015 Mar; 56(3):747-753. PubMed ID: 25598079
[TBL] [Abstract][Full Text] [Related]
8. MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine.
Yen CL; Farese RV
J Biol Chem; 2003 May; 278(20):18532-7. PubMed ID: 12621063
[TBL] [Abstract][Full Text] [Related]
9. Intestine-specific deletion of acyl-CoA:monoacylglycerol acyltransferase (MGAT) 2 protects mice from diet-induced obesity and glucose intolerance.
Nelson DW; Gao Y; Yen MI; Yen CL
J Biol Chem; 2014 Jun; 289(25):17338-49. PubMed ID: 24784138
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice.
Zhang XD; Yan JW; Yan GR; Sun XY; Ji J; Li YM; Hu YH; Wang HY
Acta Pharmacol Sin; 2010 Nov; 31(11):1470-7. PubMed ID: 21052084
[TBL] [Abstract][Full Text] [Related]
11. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
13. Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo.
Qi J; Lang W; Connelly MA; Du F; Liang Y; Caldwell GW; Martin T; Hansen MK; Kuo GH; Gaul MD; Pocai A; Lee S
Anal Biochem; 2017 May; 524():68-75. PubMed ID: 27665677
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of a series of aryl-sulfonamide derivatives that potently and selectively inhibit monoacylglycerol acyltransferase 2.
Adachi R; Ishii T; Ogawa K; Matsumoto S; Satou T; Sakamoto J; Sato K; Kawamoto T
Eur J Pharmacol; 2016 Nov; 791():569-577. PubMed ID: 27658346
[TBL] [Abstract][Full Text] [Related]
15. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
[TBL] [Abstract][Full Text] [Related]
16. Novel LC/MS/MS and High-Throughput Mass Spectrometric Assays for Monoacylglycerol Acyltransferase Inhibitors.
Qi J; Masucci JA; Lang W; Connelly MA; Caldwell GW; Petrounia I; Kirkpatrick J; Barnakov AN; Struble G; Miller R; Dzordzorine K; Kuo GH; Gaul M; Pocai A; Lee S
SLAS Discov; 2017 Apr; 22(4):433-439. PubMed ID: 28328322
[TBL] [Abstract][Full Text] [Related]
17. Cloning and functional characterization of a mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2.
Cao J; Lockwood J; Burn P; Shi Y
J Biol Chem; 2003 Apr; 278(16):13860-6. PubMed ID: 12576479
[TBL] [Abstract][Full Text] [Related]
18. JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice.
Tomimoto D; Okuma C; Ishii Y; Kobayashi A; Ohta T; Kakutani M; Imanaka T; Ogawa N
J Pharmacol Sci; 2015 Sep; 129(1):51-8. PubMed ID: 26354408
[TBL] [Abstract][Full Text] [Related]
19. Identification of 2-[2-(4-tert-butylphenyl)ethyl]-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide (29) as an orally available MGAT2 inhibitor.
Busujima T; Tanaka H; Shirasaki Y; Munetomo E; Saito M; Kitano K; Minagawa T; Yoshida K; Osaki N; Sato N
Bioorg Med Chem; 2015 Sep; 23(17):5922-31. PubMed ID: 26210160
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset deficiency of acyl CoA:monoacylglycerol acyltransferase 2 protects mice from diet-induced obesity and glucose intolerance.
Banh T; Nelson DW; Gao Y; Huang TN; Yen MI; Yen CL
J Lipid Res; 2015 Feb; 56(2):379-89. PubMed ID: 25535286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
